168 related articles for article (PubMed ID: 25148911)
1. [Transitional cell carcinoma of the bladder: bladder-sparing therapy].
Vom Dorp F; Tschirdewahn S; Szarvas T; Rübben H; Kraemer R; Rehme C
Urologe A; 2014 Sep; 53(9):1322-8. PubMed ID: 25148911
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of bladder cancer. Value of radical prostate-sparing cystectomy].
Heidenreich A; Porres D; Pfister D
Urologe A; 2012 Jun; 51(6):813-9. PubMed ID: 22278165
[TBL] [Abstract][Full Text] [Related]
3. Bladder-sparing strategies for transitional cell carcinoma.
Feneley MR; Schoenberg M
Urology; 2000 Oct; 56(4):549-60. PubMed ID: 11018601
[No Abstract] [Full Text] [Related]
4. Bladder sparing surgery in high-grade bladder cancer.
Yakovlev PG; Klyushin DA; Vereshchako RI
Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience.
Gou X; Wang M; He WY; Liu CD; Deng YZ; Ren K; Chen Y
Int Urol Nephrol; 2012 Jun; 44(3):787-92. PubMed ID: 22249369
[TBL] [Abstract][Full Text] [Related]
6. Role and Indications of Organ-Sparing "Radical" Cystectomy: The Importance of Careful Patient Selection and Counseling.
Avulova S; Chang SS
Urol Clin North Am; 2018 May; 45(2):199-214. PubMed ID: 29650136
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic prostate-sparing radical cystectomy: the Montsouris technique and preliminary results.
Arroyo C; Andrews H; Rozet F; Cathelineau X; Vallancien G
J Endourol; 2005 Apr; 19(3):424-8. PubMed ID: 15865541
[TBL] [Abstract][Full Text] [Related]
8. Organ-sparing surgery in urology: partial cystectomy.
Knoedler J; Frank I
Curr Opin Urol; 2015 Mar; 25(2):111-5. PubMed ID: 25581537
[TBL] [Abstract][Full Text] [Related]
9. [Organ-sparing treatment of bladder cancer].
Niedworok C; Shaleva A; Rübben H; Stenzl A
Urologe A; 2016 May; 55(5):609-14. PubMed ID: 27119956
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.
Supit W; Mochtar CA; Santoso RB; Umbas R
Asian J Surg; 2014 Oct; 37(4):184-9. PubMed ID: 24637186
[TBL] [Abstract][Full Text] [Related]
11. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
Stein JP; Penson DF
BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
Ge P; Wang ZC; Yu X; Lin J; He Q
BMC Urol; 2015 May; 15():46. PubMed ID: 26025446
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy.
Cho KS; Seo JW; Park SY; Cho NH; Choi YD; Yang SC; Hong SJ
Urol Int; 2008; 81(4):394-8. PubMed ID: 19077398
[TBL] [Abstract][Full Text] [Related]
14. The importance of surgical margins in renal cell and urothelial carcinomas.
Alemozaffar M; Filson CP; Master VA
J Surg Oncol; 2016 Mar; 113(3):316-22. PubMed ID: 26936428
[TBL] [Abstract][Full Text] [Related]
15. Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach.
Colombo R; Bertini R; Salonia A; Da Pozzo LF; Montorsi F; Brausi M; Roscigno M; Rigatti P
J Urol; 2001 Jan; 165(1):51-5; discussion 55. PubMed ID: 11125362
[TBL] [Abstract][Full Text] [Related]
16. Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes.
Niver BE; Daneshmand S; Satkunasivam R
Curr Opin Urol; 2015 Mar; 25(2):105-10. PubMed ID: 25581538
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Schilling D; Gakis G; Sievert KD; Stenzl A
Aktuelle Urol; 2015 Jan; 46(1):72-81. PubMed ID: 25658234
[No Abstract] [Full Text] [Related]
18. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
[TBL] [Abstract][Full Text] [Related]
19. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.
Tanabe K; Yoshida S; Koga F; Inoue M; Kobayashi S; Ishioka J; Tamura T; Sugawara E; Saito K; Akashi T; Fujii Y; Kihara K
Clin Genitourin Cancer; 2015 Aug; 13(4):e243-e251. PubMed ID: 25936588
[TBL] [Abstract][Full Text] [Related]
20. Radical cystectomy and bladder substitution.
Whittlestone TH; Persad R
Hosp Med; 2000 May; 61(5):336-40. PubMed ID: 10953740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
